Getting a modafinil prescription

This page is a reference summary of published evidence and regulatory documents. It is not a substitute for individual medical advice, and it is not a recommendation to take or avoid any medicine.

Medically reviewed by Dr. Sofia Lindqvist, · Last reviewed 11 August 2026

Modafinil is a prescription-only medicine because it carries cardiac, psychiatric, dermatologic and, in some regulatory frameworks, pregnancy-related risks that require individual screening rather than self-selection. Getting a prescription typically follows a clinical evaluation of the underlying sleep complaint, not simply a request for the drug.

Why modafinil is prescription-only

Modafinil has been associated with rare but serious skin reactions (Stevens-Johnson syndrome and related conditions), cardiovascular effects including increased heart rate and blood pressure, and psychiatric effects including anxiety and, rarely, psychosis. It is also contraindicated in pregnancy in the European Union based on registry data. These risks require a clinician to weigh a specific person’s cardiac, psychiatric and reproductive history before treatment starts, which is the function a prescription requirement serves.

Which conditions lead to a prescription

The FDA-approved indications are narcolepsy, obstructive sleep apnea with excessive sleepiness that persists despite adequate CPAP treatment, and shift work sleep disorder. A prescription for any of these follows a diagnostic process specific to that condition rather than a symptom report alone.

What a sleep evaluation involves

Evaluation typically starts with a clinical history and a sleep diary kept over one to two weeks, sometimes supplemented by actigraphy — a wrist-worn device that estimates sleep-wake patterns from movement. Where narcolepsy or significant sleep-disordered breathing is suspected, this is followed by an overnight polysomnogram, which records brain activity, breathing, oxygen levels and movement during sleep.

The polysomnogram is usually followed the next day by a Multiple Sleep Latency Test (MSLT): a series of scheduled daytime nap opportunities used to measure how quickly a person falls asleep and whether REM sleep occurs abnormally early. A mean sleep latency under 8 minutes together with two or more sleep-onset REM periods (SOREMPs) supports a narcolepsy diagnosis.

The evaluation also serves to differentiate narcolepsy from other causes of daytime sleepiness, including obstructive sleep apnea, depression, and simple insufficient sleep syndrome, each of which is managed differently.

What a prescriber screens for

Pre-treatment screening

Before prescribing, clinicians typically review cardiac history and blood pressure, psychiatric history including any history of psychosis or mania, skin reaction history to any prior medication, current medications for interaction risk, and pregnancy status or contraceptive method where relevant.

What to expect from the process

The process generally moves from a primary care or sleep medicine consultation, through diagnostic testing where indicated, to a treatment discussion once a diagnosis is established. Timelines vary by health system and by how quickly polysomnography and MSLT appointments are available; in many settings this takes weeks rather than a single visit.

Why persistent sleepiness warrants evaluation regardless

Undiagnosed obstructive sleep apnea carries cardiovascular risk — including elevated risk of hypertension and cardiovascular events — independent of how sleepy a person subjectively feels. Persistent daytime sleepiness is worth medical evaluation on that basis alone, separate from any question of stimulant treatment.

Frequently asked questions

Why can't modafinil be bought without a prescription?

It carries cardiac, psychiatric and dermatologic risks, along with a pregnancy-related contraindication in some jurisdictions, that require individual screening before use; regulators classify it as a prescription-only medicine for this reason.

What is the MSLT and why does it matter?

The Multiple Sleep Latency Test measures how quickly a person falls asleep in a series of daytime nap opportunities; a mean sleep latency under 8 minutes with sleep-onset REM periods supports a narcolepsy diagnosis and is part of the standard evaluation before stimulant treatment.

Which conditions commonly lead to a modafinil prescription?

Narcolepsy, obstructive sleep apnea with residual sleepiness despite treatment, and shift work sleep disorder are the FDA-approved indications; other uses are off-label.

What does a sleep evaluation actually involve?

A clinical history, a sleep diary, often actigraphy, and frequently an overnight polysomnogram followed by a Multiple Sleep Latency Test, used to rule out and rule in specific sleep disorders before treatment is chosen.

Is it worth getting evaluated for persistent daytime sleepiness even without narcolepsy in mind?

Yes. Undiagnosed obstructive sleep apnea carries cardiovascular risk independent of how sleepy a person feels, so persistent sleepiness is worth investigating regardless of whether a stimulant is being considered.